Toshio Moritani

Prof. Toshio Moritani


Research Focus & Metrics

Academic Career Length

46Years (1981-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2018 in European Review of Aging and Physical Activity
Verified
Journal Article
Open access
PDF file
KWKohei Watanabe
Kohei Watanabe
MKMotoki Kouzaki
Motoki Kouzaki
MOMadoka Ogawa
Madoka Ogawa
HAHiroshi Akima
Hiroshi Akima
TMToshio Moritani
Toshio Moritani
Since age-related muscle strength loss cannot be explained solely by muscle atrophy, other determinants would also contribute to muscle strength in elderly. The present study aimed to clarify contribution of neuromuscular activation pattern to muscle strength in elderly group. From 88 elderlies (age: 61~ 83 years), multi-channel surface electromyography (EMG) of the vastus lateralis muscle was recorded with two-dimensional 64 electrodes during isometric submaximal ramp-up knee extension to assess neuromuscular activation pattern. Correlation analysis and stepwise regression analysis were performed between muscle strength and the parameters for signal amplitude and spatial distribution pattern, i.e., root mean square (RMS), correlation coefficient, and modified entropy of multi-channel surface EMG. There was a significant correlation between muscle strength and RMS (r = 0.361, p = 0.001) in the elderly. Muscle thickness (r = 0.519, p < 0.001), RMS (r = 0.288, p = 0.001), and normalized RMS (r = 0.177, p = 0.047) were selected as major determinants of muscle strength in stepwise regression analysis (r = 0.664 in the selected model). These results suggest that inter-individual difference in muscle strength in elderly can be partly explained by surface EMG amplitude. We concluded that neuromuscular activation pattern is also major determinants of muscle strength on elderly in addition to indicator of muscle volume.

4 May 2021 in Exercise and Sport Sciences Reviews
Verified
Journal Article
Open access
KWKohei Watanabe
Kohei Watanabe
TVTaian Vieira
Taian Vieira
AGAlessio Gallina
Alessio Gallina
MKMotoki Kouzaki
Motoki Kouzaki
TMToshio Moritani
Toshio Moritani
Biarticular muscles have traditionally been considered to exhibit homogeneous neuromuscular activation. The regional activation of biarticular muscles, as revealed from high-density surface electromyograms, seems however to discredit this notion. We thus hypothesize the regional activation of biarticular muscles may contribute to different actions about the joints they span. We then discuss the mechanistic basis and methodological implications underpinning our hypothesis.

23 June 2020 in Nutrients
Verified
Journal Article
Open access
PDF file
CRClaire Boutry Regard
Claire Boutry Regard
GVGerard Vinyes-Parés
Gerard Vinyes-Parés
DBDenis Breuillé
Denis Breuillé
TMToshio Moritani
Toshio Moritani
Age-related sarcopenia is a progressive and generalized skeletal muscle disorder associated with adverse outcomes. Herein, we evaluate the effects of a combination of electrical muscle stimulation (EMS) and a whey-based nutritional supplement (with or without polyphenols and fish oil-derived omega-3 fatty acids) on muscle function and size. Free-living elderly participants with mobility limitations were included in this study. They received 2 sessions of EMS per week and were randomly assigned to ingest an isocaloric beverage and capsules for 12 weeks: (1) carbohydrate + placebo capsules (CHO, n = 12), (2) whey protein isolate + placebo capsules (WPI, n = 15) and (3) whey protein isolate + bioactives (BIO) capsules containing omega-3 fatty acids, rutin, and curcumin (WPI + BIO, n = 10). The change in knee extension strength was significantly improved by 13% in the WPI + BIO group versus CHO on top of EMS, while WPI alone did not provide a significant benefit over CHO. On top of this, there was the largest improvement in gait speed (8%). The combination of EMS and this specific nutritional intervention could be considered as a new approach for the prevention of sarcopenia but more work is needed before this approach should be recommended. This trial was registered at the Japanese University Hospital Medical Information Network (UMIN) clinical trial registry (UMIN000008382).

1 December 2015 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
PDF file
PHPatrick W Hitchon
Patrick W Hitchon
MZMario Zanaty
Mario Zanaty
TMToshio Moritani
Toshio Moritani
EUErgun Uc
Ergun Uc
CPConnie L. Pieper
Connie L. Pieper
JNJennifer Noeller
Jennifer Noeller

1 February 2003
Verified
Journal Article
Closed access
AHAkio Hiwatashi
Akio Hiwatashi
TMToshio Moritani
Toshio Moritani
YNYuji Numaguchi
Yuji Numaguchi
PWPer-Lennart Westesson
Per-Lennart Westesson

1 March 2018 in Schizophrenia Research
Verified
Journal Article
Closed access
SHSaki Hattori
Saki Hattori
IKIkuko Kishida
Ikuko Kishida
ASAkira Suda
Akira Suda
MMMasatoshi Miyauchi
Masatoshi Miyauchi
YSYohko Shiraishi
Yohko Shiraishi
YHYoshio Hirayasu
Yoshio Hirayasu